Literature DB >> 19622411

Chapter 5. Potential contribution of sero-epidemiological analysis for monitoring malaria control and elimination: historical and current perspectives.

Chris Drakeley1, Jackie Cook.   

Abstract

Anti-malarial antibody responses represent an individual's history of exposure to the disease and, as age sero-conversion rates, reflect cumulative malaria exposure in a population. As such these antibody responses are an alternate measure of malaria transmission intensity and have potential in evaluating changes in exposure. This approach was used in the 1970s to evaluate malaria control and eradication attempts in a variety of different ecological settings. These historical studies provided a wealth of information on how serological data might be used to interpret control measures. However they were limited by a lack of standardized antigens and reproducible high-throughput assays. Current techniques using recombinant antigens with a range of immunogenicities, high-throughput enzyme-linked immunosorbent assays (ELISA) and statistical analysis allow a more robust examination of how serological parameters can be used to evaluate factors affecting malaria transmission. Here we present a review of the historical data and use it to assess the serological contribution to monitoring malaria elimination.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19622411     DOI: 10.1016/S0065-308X(09)69005-9

Source DB:  PubMed          Journal:  Adv Parasitol        ISSN: 0065-308X            Impact factor:   3.870


  65 in total

1.  Assessment of antibody responses in local and immigrant residents of areas with autochthonous malaria transmission in Greece.

Authors:  Evangelia-Theofano Piperaki; Maria Mavrouli; Maria Tseroni; John Routsias; Athina Kallimani; Lamprini Veneti; Maria Georgitsou; Maria Chania; Theano Georgakopoulou; Christos Hadjichristodoulou; Athanassios Tsakris
Journal:  Am J Trop Med Hyg       Date:  2015-05-26       Impact factor: 2.345

2.  Anti-MSP-10 IgG indicates recent exposure to Plasmodium vivax infection in the Peruvian Amazon.

Authors:  Angel Rosas-Aguirre; Kailash P Patra; Maritza Calderón; Katherine Torres; Dionicia Gamboa; Edith Arocutipa; Edith Málaga; Katherine Garro; Carlos Fernández; Grace Trompeter; Yossef Alnasser; Alejandro Llanos-Cuentas; Robert H Gilman; Joseph M Vinetz
Journal:  JCI Insight       Date:  2020-01-16

Review 3.  Measuring changes in Plasmodium falciparum transmission: precision, accuracy and costs of metrics.

Authors:  Lucy S Tusting; Teun Bousema; David L Smith; Chris Drakeley
Journal:  Adv Parasitol       Date:  2014       Impact factor: 3.870

4.  Differing rates of antibody acquisition to merozoite antigens in malaria: implications for immunity and surveillance.

Authors:  Fiona J McCallum; Kristina E M Persson; Freya J I Fowkes; Linda Reiling; Cleopatra K Mugyenyi; Jack S Richards; Julie A Simpson; Thomas N Williams; Paul R Gilson; Anthony N Hodder; Paul R Sanders; Robin F Anders; David L Narum; Chetan Chitnis; Brendan S Crabb; Kevin Marsh; James G Beeson
Journal:  J Leukoc Biol       Date:  2016-11-11       Impact factor: 4.962

5.  The shape of the iceberg: quantification of submicroscopic Plasmodium falciparum and Plasmodium vivax parasitaemia and gametocytaemia in five low endemic settings in Ethiopia.

Authors:  Fitsum G Tadesse; Lotus van den Hoogen; Kjerstin Lanke; Jodie Schildkraut; Kevin Tetteh; Abraham Aseffa; Hassen Mamo; Robert Sauerwein; Ingrid Felger; Chris Drakeley; Endalamaw Gadissa; Teun Bousema
Journal:  Malar J       Date:  2017-03-03       Impact factor: 2.979

6.  Using serological measures to monitor changes in malaria transmission in Vanuatu.

Authors:  Jackie Cook; Heidi Reid; Jennifer Iavro; Melissa Kuwahata; George Taleo; Archie Clements; James McCarthy; Andrew Vallely; Chris Drakeley
Journal:  Malar J       Date:  2010-06-16       Impact factor: 2.979

7.  Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities.

Authors:  Danica A Helb; Kevin K A Tetteh; Philip L Felgner; Jeff Skinner; Alan Hubbard; Emmanuel Arinaitwe; Harriet Mayanja-Kizza; Isaac Ssewanyana; Moses R Kamya; James G Beeson; Jordan Tappero; David L Smith; Peter D Crompton; Philip J Rosenthal; Grant Dorsey; Christopher J Drakeley; Bryan Greenhouse
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-27       Impact factor: 11.205

8.  Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development.

Authors:  Jack S Richards; Thangavelu U Arumugam; Linda Reiling; Julie Healer; Anthony N Hodder; Freya J I Fowkes; Nadia Cross; Christine Langer; Satoru Takeo; Alex D Uboldi; Jennifer K Thompson; Paul R Gilson; Ross L Coppel; Peter M Siba; Christopher L King; Motomi Torii; Chetan E Chitnis; David L Narum; Ivo Mueller; Brendan S Crabb; Alan F Cowman; Takafumi Tsuboi; James G Beeson
Journal:  J Immunol       Date:  2013-06-17       Impact factor: 5.422

Review 9.  Application of genomics to field investigations of malaria by the international centers of excellence for malaria research.

Authors:  Sarah K Volkman; Daouda Ndiaye; Mahamadou Diakite; Ousmane A Koita; Davis Nwakanma; Rachel F Daniels; Daniel J Park; Daniel E Neafsey; Marc A T Muskavitch; Donald J Krogstad; Pardis C Sabeti; Daniel L Hartl; Dyann F Wirth
Journal:  Acta Trop       Date:  2011-12-13       Impact factor: 3.112

10.  Increased risks of malaria due to limited residual life of insecticide and outdoor biting versus protection by combined use of nets and indoor residual spraying on Bioko Island, Equatorial Guinea.

Authors:  John Bradley; Abrahan Matias; Christopher Schwabe; Daniel Vargas; Feliciano Monti; Gloria Nseng; Immo Kleinschmidt
Journal:  Malar J       Date:  2012-07-26       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.